Recent 13F filings as of September 2025 show that 1218 institutional investors hold a position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 30 Sep, 2025 | 9,048,269 | -375,779 | -3.99% | $5,087,570,211.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 8,837,174 | -438,911 | -4.73% | $4,968,878,140.00 |
| STATE STREET CORP | 30 Sep, 2025 | 4,691,223 | -140,779 | -2.91% | $2,637,733,956.00 |
| DODGE & COX | 30 Sep, 2025 | 4,550,845 | 724,562 | 18.94% | $2,558,803,618.00 |
| JPMORGAN CHASE & CO | 30 Sep, 2025 | 4,072,326 | 132,708 | 3.37% | $2,289,760,415.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 2,535,898 | 70,844 | 2.87% | $1,419,627,369.00 |
| FRANKLIN RESOURCES INC | 30 Sep, 2025 | 2,453,143 | 139,647 | 6.04% | $1,379,328,713.00 |
| Capital World Investors | 30 Sep, 2025 | 1,998,366 | 32,348 | 1.65% | $1,123,608,855.00 |
| LOOMIS SAYLES & CO L P | 30 Sep, 2025 | 1,979,453 | 38,383 | 1.98% | $1,112,987,056.00 |
| FMR LLC | 30 Sep, 2025 | 1,935,835 | -1,391,216 | -41.82% | $1,088,462,214.00 |
| Invesco Ltd. | 30 Sep, 2025 | 1,484,473 | 408,649 | 37.98% | $834,674,573.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 1,450,972 | 163,309 | 12.68% | $815,840,196.00 |
| GOLDMAN SACHS GROUP INC | 30 Sep, 2025 | 1,241,139 | 148,433 | 13.58% | $697,855,390.00 |
| Nuveen, LLC | 30 Sep, 2025 | 1,175,277 | 333,728 | 39.66% | $660,822,999.00 |
| BANK OF AMERICA CORP /DE/ | 30 Sep, 2025 | 1,153,933 | -66,426 | -5.44% | $648,821,756.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 984,792 | 26,223 | 2.74% | $553,718,997.00 |
| TWO SIGMA ADVISERS, LP | 30 Sep, 2025 | 926,200 | -12,300 | -1.31% | $520,774,474.00 |
| Capital International Investors | 30 Sep, 2025 | 876,564 | -2,288,699 | -72.31% | $492,851,584.00 |
| D. E. Shaw & Co., Inc. | 30 Sep, 2025 | 861,593 | 84,124 | 10.82% | $484,447,896.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 30 Sep, 2025 | 804,910 | 38,466 | 5.02% | $452,578.00 |